Takeda Partners with Insilico for Groundbreaking AI-Driven Drug Discovery Deal
Takeda Pharmaceutical Company has entered into a strategic partnership with Insilico Medicine, focusing on AI-led drug discovery. The deal, valued at up to $600 million, aims to accelerate the development of innovative therapies.